Novartis AG · Healthcare
$127.92
-0.1%
Jul 5, 2026
D
WeakGraded against NOVN's own history at this drawdown — not the market's.
What it means: NOVN's own history does not strongly favor buying at this level yet.
What to do: Consider watching and waiting for a deeper dip or a higher grade.
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CD
Three plain-English paragraphs — current state, historical base rate, and interpretation — so you walk away with context, not a dashboard.
In plain terms: NOVN is 0.1% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
Novartis AG (NOVN) sits 0.1% off its peak and is currently at or near all-time highs, last printing at $127.92. That puts NOVN in a momentum regime: buyers are in control and there's no meaningful technical damage on the chart yet.
History at this drawdown level is well-populated for NOVN — 2461 confirmed observations in the 5%-to-0% band. The Dipsern engine uses these to compute a rolling median rather than a mean, because medians are robust to the kind of fat tails you find in european stocks return distributions. The win rate (% of episodes that closed positive after 90 days) is shown in the segments table below.
Drawdown-based signals work across asset classes but the magnitude of meaningful moves varies. Dipsern computes the segmentation per-asset so the bands are calibrated to NOVN's own volatility history. At this level the Dipsern signal is mostly tracking momentum, not mean reversion. Most buying-the-dip frameworks aren't relevant when there is no dip.
Five tickers closest to NOVN's distance from all-time high. Same category, one tap away.
Dipsern segments the full drawdown range into 20 equal-width bands. The table shows the number of confirmed historical observations in each band for NOVN. Median forward returns, win rates, and prediction errors are available in the full analysis.
We segment 40+ years of NOVN's price history into 20 equal-width drawdown bands and compute forward median returns, win rates, and prediction error per band. No look-ahead bias. Pure NumPy. Open math, gated numbers.
Years of history
40+
Drawdown bands
20
Look-ahead bias
None
Data sources
4
See the Dipsern grade, median returns, win rates, prediction accuracy, 8 interactive charts, historical price paths, and a plain-English verdict for NOVN.
Dipsern is research and a second opinion — not a broker. You'd buy NOVN at your own broker.
Analyze NOVN FreeNo credit card required · 5 free analyses per month
Signal computed Jul 5, 2026 using default parameters (90-day return period, 20 segments, 0.95 decay). Data sourced from Yahoo Finance, Binance, CoinGecko, and Steam Market.